HIMS Form 144: Insider Oluyemi Okupe Sells Shares

HIMS reported Form 144 sales by Oluyemi Okupe, who sold multiple blocks of Common Stock on various dates.

Rhea-AI Filing Summary

HIMS reported Form 144 sales by Oluyemi Okupe, who sold multiple blocks of Common Stock on various dates. The filing lists specific sale transactions including 4,490 shares on 02/03/2026 and 3,658 shares on 04/06/2026 with dollar proceeds recorded for each trade.

Insights

Corporate Governance Analyst

Insider reported several open-market dispositions; filings list per-trade shares and proceeds.

The filing shows multiple sales by Oluyemi Okupe of Common Stock on discrete dates with per-transaction proceeds recorded. Each row pairs a trade date, a share count and a dollar amount, indicating completed dispositions rather than grants or exercises.

These are routine Form 144 disclosures that document sales; the listed transactions should be read as individual dispositions recorded on the indicated dates.

Key Figures

Sale on 04/06/2026: 3,658 shares Proceeds for 04/06/2026 sale: $73,075.87 Sale on 02/03/2026: 4,490 shares +3 more

6 metrics

Sale on 04/06/2026 3,658 shares sale recorded 04/06/2026

Proceeds for 04/06/2026 sale $73,075.87 proceeds reported for 3,658-share trade

Sale on 02/03/2026 4,490 shares sale recorded 02/03/2026

Proceeds for 02/03/2026 example $118,634.33 proceeds reported for 4,490-share trade

Sale on 03/20/2026 4,728 shares sale recorded 03/20/2026

RSU grant on 03/15/2026 184,609 shares Acquired as compensation — Restricted Stock Units dated 03/15/2026

Key Terms

Form 144, Restricted Stock Units, Cashless exercise / same-day sale, Issuer

4 terms

Form 144 regulatory

"Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Acquired as compensation -- Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Cashless exercise / same-day sale financial

"Acquired as compensation -- Stock Options ... Compensation -- Cashless exercise / same-day sale"

Issuer regulatory

"Acquired as compensation -- Stock Options | Issuer"

FAQ

Who sold shares in the HIMS Form 144?

The filing shows Oluyemi Okupe as the reporting seller on multiple dates. The record lists individual sale transactions with share counts and proceeds attributed to that name.

How many shares were sold on 04/06/2026 in the HIMS Form 144?

The filing records a sale of 3,658 shares on 04/06/2026 with proceeds of $73,075.87. That entry appears as one of several dated transactions in the Form 144 excerpt.

Are the proceeds for each HIMS sale listed in the Form 144?

Yes; each transaction row in the excerpt pairs a share count with a dollar amount. Examples include 4,490 shares — $118,634.33 and 4,489 shares — $135,990.66 on the listed dates.

Do the entries include how the shares were originally acquired?

The excerpt shows acquisition types for other securities (e.g., Stock Options, Restricted Stock Units) but the sale rows attribute the dispositions to Oluyemi Okupe without restating original acquisition method.

Which dates show sales in the provided HIMS excerpt?

Recorded sale dates include 01/05/2026, 01/20/2026, 02/03/2026, 03/20/2026, and 04/06/2026, each tied to specific share counts and proceeds in the table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/06/2026 - 06:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001907056
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hims & Hers Health, Inc.
SEC File Number	001-38986
Address of Issuer	2269 Chestnut Street Suite 523 San Francisco CALIFORNIA 94123
Phone	1-415-851-0195
Name of Person for Whose Account the Securities are To Be Sold	Oluyemi Okupe
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	240560	4890584.8	219561143	04/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2023	Acquired as compensation -- Stock Options	Issuer			7212	03/01/2023	Compensation -- Cashless exercise / same-day sale
Common	02/24/2022	Acquired as compensation -- Stock Options	Issuer			29826	02/24/2022	Compensation -- Cashless exercise / same-day sale
Common	03/15/2026	Acquired as compensation -- Restricted Stock Units	Issuer			184609	03/15/2026	Compensation
Common	03/15/2026	Acquired as compensation -- Restricted Stock Units	Issuer			9421	03/15/2026	Compensation
Common	03/15/2026	Acquired as compensation -- Restricted Stock Units	Issuer			3296	03/15/2026	Compensation
Common	03/15/2026	Acquired as compensation -- Restricted Stock Units	Issuer			4132	03/15/2026	Compensation
Common	03/15/2026	Acquired as compensation -- Restricted Stock Units	Issuer			2064	03/15/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	02/03/2026	4490	118634.33
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	01/05/2026	3808	128984.58
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	01/05/2026	772	26093.6
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	01/20/2026	4489	135990.66
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	01/05/2026	4490	151374.06
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	02/03/2026	772	20473.52
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	01/20/2026	771	23406.56
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	03/20/2026	4728	112197.8
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	01/20/2026	3807	115716.05
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	03/20/2026	4489	106868.73
Oluyemi Okupe 2269 Chestnut Street Suite 523 San Francisco CA 94123	Common	04/06/2026	3658	73075.87

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 5/21/2025, that is intended to comply with Rule 10b5-1(c).
Date of Notice	04/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Oluyemi Okupe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)